Glucagon-like peptide 1 Analogues as Adjunctive Therapy for Patients with Type 1 Diabetes: an Updated Systematic Review and Meta-analysis.
Jeayoung ParkSpyridon NtelisElvina YunasanKatherine D DowntonTerry Cheuk Fung YipKashif M MunirNowreen HaqPublished in: The Journal of clinical endocrinology and metabolism (2023)
Our meta-analysis supports the therapeutic benefits of liraglutide for patients with T1DM mainly for weight loss and insulin dose reduction. Newly diagnosed or C-pos patients do not appear to experience greater weight loss benefits.
Keyphrases
- newly diagnosed
- weight loss
- systematic review
- bariatric surgery
- end stage renal disease
- glycemic control
- roux en y gastric bypass
- ejection fraction
- chronic kidney disease
- gastric bypass
- prognostic factors
- peritoneal dialysis
- molecular docking
- metabolic syndrome
- body mass index
- insulin resistance
- patient reported
- adipose tissue
- structure activity relationship